RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Novo Nordisk A/S Employees 2024

Novo Nordisk A/S Employees

43,158

Novo Nordisk A/S Dividend yield

1.63 %

Ticker

NOVO B.CO

ISIN

DK0060534915

WKN

A1XA8R

In 2024, Novo Nordisk A/S employed 43,158 people, a 0% change from the 43,158 number of employees in the previous year.

Novo Nordisk A/S Aktienanalyse

What does Novo Nordisk A/S do?

Novo Nordisk A/S is a Danish company specializing in the production of insulin and other diabetes medications. It was founded in 1923 and has its headquarters in Bagsværd, Denmark. Novo Nordisk is the world's largest manufacturer of insulin and one of the key players in the field of diabetes treatment. Novo Nordisk A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Novo Nordisk A/S's Employee Base

Novo Nordisk A/S's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Novo Nordisk A/S's operational capacity and future potential.

Year-to-Year Comparison

Assessing Novo Nordisk A/S's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Novo Nordisk A/S's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Novo Nordisk A/S’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Novo Nordisk A/S Stock

How many employees does Novo Nordisk A/S have this year?

Novo Nordisk A/S has 43,158 undefined employees this year.

How many employees did Novo Nordisk A/S have compared to the previous year?

Compared to the previous year, Novo Nordisk A/S had 0% more employees.

What impact did the number of employees have on the company Novo Nordisk A/S?

The number of employees has a direct impact on the efficiency and productivity of Novo Nordisk A/S. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Novo Nordisk A/S?

The number of employees can also have an impact on investors of Novo Nordisk A/S, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Novo Nordisk A/S affect the company?

An increase in equity of Novo Nordisk A/S can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Novo Nordisk A/S's equity affect the company?

A reduction in equity of Novo Nordisk A/S can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Novo Nordisk A/S?

Some factors that can influence the equity of Novo Nordisk A/S include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Novo Nordisk A/S so important for investors?

The equity of Novo Nordisk A/S is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Novo Nordisk A/S influence the company?

The number of employees at Novo Nordisk A/S can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Novo Nordisk A/S evolved in recent years?

In recent years, the number of employees at Novo Nordisk A/S has changed by 0.

How many employees does Novo Nordisk A/S currently have?

Novo Nordisk A/S currently has 43,158 undefined employees.

Why is the number of employees important for investors of Novo Nordisk A/S?

The number of employees is important for investors of Novo Nordisk A/S as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Novo Nordisk A/S take to change the number of employees?

To change the number of employees, Novo Nordisk A/S can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Novo Nordisk A/S pay?

Over the past 12 months, Novo Nordisk A/S paid a dividend of 14.15 DKK . This corresponds to a dividend yield of about 1.63 %. For the coming 12 months, Novo Nordisk A/S is expected to pay a dividend of 14.94 DKK.

What is the dividend yield of Novo Nordisk A/S?

The current dividend yield of Novo Nordisk A/S is 1.63 %.

When does Novo Nordisk A/S pay dividends?

Novo Nordisk A/S pays a quarterly dividend. This is distributed in the months of September, April, September, April.

How secure is the dividend of Novo Nordisk A/S?

Novo Nordisk A/S paid dividends every year for the past 26 years.

What is the dividend of Novo Nordisk A/S?

For the upcoming 12 months, dividends amounting to 14.94 DKK are expected. This corresponds to a dividend yield of 1.72 %.

In which sector is Novo Nordisk A/S located?

Novo Nordisk A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novo Nordisk A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novo Nordisk A/S from 3/26/2024 amounting to 6.4 DKK, you needed to have the stock in your portfolio before the ex-date on 3/22/2024.

When did Novo Nordisk A/S pay the last dividend?

The last dividend was paid out on 3/26/2024.

What was the dividend of Novo Nordisk A/S in the year 2023?

In the year 2023, Novo Nordisk A/S distributed 11.15 DKK as dividends.

In which currency does Novo Nordisk A/S pay out the dividend?

The dividends of Novo Nordisk A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Novo Nordisk A/S stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Novo Nordisk A/S

Our stock analysis for Novo Nordisk A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novo Nordisk A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.